{"count": 4, "results": [{"_id": "32872631", "pmid": 32872631, "pmcid": "PMC7503978", "title": "Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type", "journal": "Int J Environ Res Public Health", "authors": ["Kim J", "Kim HS", "Yang W", "Lee JW", "Kang HT"], "date": "2020-08-30T00:00:00Z", "doi": "10.3390/ijerph17176309", "meta_date_publication": "2020 Aug 30", "meta_volume": "17", "meta_issue": "17", "meta_pages": "", "score": 50259.527, "text_hl": "Primary Prevention of @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@Cardiocerebrovascular Diseases@@@ and Related Deaths According to Statin Type", "citations": {"NLM": "Kim J, Kim HS, Yang W, Lee JW, Kang HT. Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type Int J Environ Res Public Health. 2020 Aug 30;17(17):. PMID: 32872631", "BibTeX": "@article{32872631, title={Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type}, author={Kim J and Kim HS and Yang W and Lee JW and Kang HT}, journal={Int J Environ Res Public Health}, volume={17}, number={17}}"}}, {"_id": "15886498", "pmid": 15886498, "title": "Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.", "journal": "Nephron Exp Nephrol", "authors": ["Zhu B", "Shen H", "Zhou J", "Lin F", "Hu Y"], "date": "2005-01-01T00:00:00Z", "doi": "10.1159/000085712", "meta_date_publication": "2005", "meta_volume": "101", "meta_issue": "1", "meta_pages": "e1-8", "score": 50044.33, "text_hl": "CONCLUSION: Increased @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ peroxidation and decreased antioxidant enzymes in plasma may play a role in the progression of @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ may ameliorate these changes to protect kidney from @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@oxidative lesion@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ even in the absence of @DISEASE_Pneumonia_Lipid @DISEASE_MESH:D011017 @@@lipid abnormalities@@@.", "citations": {"NLM": "Zhu B, Shen H, Zhou J, Lin F, Hu Y. Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection. Nephron Exp Nephrol. 2005;101(1):e1-8. PMID: 15886498", "BibTeX": "@article{15886498, title={Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.}, author={Zhu B and Shen H and Zhou J and Lin F and Hu Y}, journal={Nephron Exp Nephrol}, volume={101}, number={1}, pages={e1-8}}"}}, {"_id": "26282344", "pmid": 26282344, "title": "Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials.", "journal": "Clin Cardiol", "authors": ["Thomopoulos C", "Skalis G", "Michalopoulou H", "Tsioufis C", "Makris T"], "date": "2015-12-01T00:00:00Z", "doi": "10.1002/clc.22441", "meta_date_publication": "2015 Dec", "meta_volume": "38", "meta_issue": "12", "meta_pages": "763-9", "score": 50041.227, "text_hl": "Our meta-analysis provides evidence that, in @SPECIES_9606 @@@patients@@@ with different @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@CV disease@@@ burden, major CV events are safely reduced by LDL-C lowering with @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, while raising the hypothesis that the extent of LDL-C lowering might not be accompanied by incremental clinical-event reduction.", "citations": {"NLM": "Thomopoulos C, Skalis G, Michalopoulou H, Tsioufis C, Makris T. Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials. Clin Cardiol. 2015 Dec;38(12):763-9. PMID: 26282344", "BibTeX": "@article{26282344, title={Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials.}, author={Thomopoulos C and Skalis G and Michalopoulou H and Tsioufis C and Makris T}, journal={Clin Cardiol}, volume={38}, number={12}, pages={763-9}}"}}, {"_id": "27021071", "pmid": 27021071, "title": "Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.", "journal": "J Neurovirol", "authors": ["Yadav A", "Betts MR", "Collman RG"], "date": "2016-10-01T00:00:00Z", "doi": "10.1007/s13365-016-0433-8", "meta_date_publication": "2016 Oct", "meta_volume": "22", "meta_issue": "5", "meta_pages": "584-596", "score": 50035.44, "text_hl": "Treatment ex vivo with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ reduced the proportion of @GENE_FCGR3A @GENE_2214 @@@CD16@@@+ monocytes in peripheral blood mononuclear cells, as well as in purified monocytes, especially @GENE_CD14 @GENE_929 @@@CD14@@@++@GENE_FCGR3A @GENE_2214 @@@CD16@@@+ \"intermediate\" monocytes most closely associated with @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@neurocognitive disease@@@. ", "citations": {"NLM": "Yadav A, Betts MR, Collman RG. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol. 2016 Oct;22(5):584-596. PMID: 27021071", "BibTeX": "@article{27021071, title={Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.}, author={Yadav A and Betts MR and Collman RG}, journal={J Neurovirol}, volume={22}, number={5}, pages={584-596}}"}}]}